首页> 美国卫生研究院文献>Pharmaceutics >Ginsenoside Drug Nanocomposites Prepared by the Aerosol Solvent Extraction System for Enhancing Drug Solubility and Stability
【2h】

Ginsenoside Drug Nanocomposites Prepared by the Aerosol Solvent Extraction System for Enhancing Drug Solubility and Stability

机译:通过气溶胶溶剂萃取系统制备的人参皂苷药物纳米复合物可增强药物的溶解度和稳定性

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Ginsenosides are the pharmacologically active constituents of ginseng. So far, more than 30 ginsenosides have been identified and widely used in pharmaceutical formulations. However, the therapeutic applications of ginsenosides are hampered by their poor solubility and low bioavailability. In this study, we selected two of the most important ginsenosides-Re and Rh2 as model drugs to prepare ginsenoside drug nanocomposites (NanoGS) using the simple aerosol solvent extraction system (ASES) technique to address the poor solubility and bioavailability of these compounds. Compared with raw ginsenosides, NanoGS exhibited significantly enhanced dissolution rate owing to their low crystallinity and high surface area. Furthermore, in vitro cellular investigations showed that NanoGS-Rh2 exhibited outstanding anticancer activity against MCF-7 cancer cells. Therefore, this study is expected to provide a promising strategy that could optimize and broaden the applications of ginsenosides, as well as other water-insoluble drugs in pharmaceutical formulations.
机译:人参皂苷是人参的药理活性成分。迄今为止,已鉴定出30多种人参皂苷,并将其广泛用于药物制剂中。但是,人参皂甙的治疗应用因其不良的溶解性和较低的生物利用度而受到阻碍。在这项研究中,我们选择了两种最重要的人参皂甙Re和Rh2作为模型药物,使用简单的气溶胶溶剂萃取系统(ASES)技术来制备人参皂甙纳米复合材料(NanoGS),以解决这些化合物的不良溶解性和生物利用度。与人参皂甙相比,NanoGS由于其低结晶度和高表面积而显示出显着提高的溶解速度。此外,体外细胞研究表明,NanoGS-Rh2对MCF-7癌细胞表现出出色的抗癌活性。因此,该研究有望提供一种有前途的策略,可以优化和扩大人参皂苷以及其他水不溶性药物在药物制剂中的应用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号